Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Trading Statement

19 Jan 2021 07:00

RNS Number : 0821M
Alumasc Group PLC
19 January 2021
 

19 January 2021

THE ALUMASC GROUP PLC

("ALUMASC")

TRADING UPDATE FOR SIX MONTHS ENDED 31 DECEMBER 2020

 

Alumasc, the premium building products, systems, and solutions Group, today provides a trading update for the six months ended 31 December 2020, ahead of publication of its half-year results on Thursday 4 February 2021.

Our absolute focus continues to be the safety of our employees, customers, suppliers, and sub-contractors as we continue to manage with the Covid-19 pandemic and the latest lockdown guidelines.

Record Half Year Performance

Further to our AGM Trading Update on 22 October 2020, which reported a strong performance in the first quarter, we are very pleased to report that conditions in our markets have remained positive and that the Group's trading performance has continued through to the end of the first half of the financial year, with a record profit for the period being achieved. On an unaudited basis, for the first six months of the year:

· Revenue increased 11% versus the prior year to £45.6m

· Underlying PBT increased significantly, from £2.3m to £6.0m

· Cash generation has also been strong in the first half, with net bank debt reducing from £4.3m at 30 June 2020 to £0.2m at 31 December 2020.

 

Pleasingly, all our divisions have contributed to the strong performance. While trading in the period includes an element of catch-up demand following the UK's first national lockdown and has benefitted from a range of Government support for the construction industry, our businesses have also been successful in winning market share and have been further supported by encouraging export sales. Additionally, the restructuring during FY2020, which provided £2.4 million in annual cost savings, benefitted margins. Levolux also continues to respond well to the business's turnaround plan, achieving a profit in each month of the first half of this financial year.

Outlook

The business has entered H2 with good momentum, a healthy forward sales position, and a well-capitalised balance sheet, creating the potential to deliver a strong result for the year. Nevertheless, we remain mindful of the continued economic uncertainties, particularly the risk of disruption to our business and markets in the near term as a result of the on-going pandemic and the establishment of efficient cross-border goods movement following the entry into the Free Trade Agreement with the EU. Conditions in our markets, particularly in the new build housing and RMI sectors, have been very supportive coming into the second half and we would anticipate demand remaining good through the coming months. We are also continuing to monitor the potential impact of changes to UK Government incentives within the housebuilding industry, notably around the current Help to Buy Scheme being extended beyond 28 February 2021 and Stamp Duty and changes here may affect our final quarter, albeit the potential impact is difficult to predict. However, we are encouraged by the UK's accelerating rollout of vaccines and mass testing, which should provide some counterbalance in our markets. Overall, this has been a most encouraging performance by Alumasc in the first half and there is an excellent platform to deliver sustainable shareholder value.

Paul Hooper, CEO, commented, "It is very encouraging to see Alumasc's achievement of a double digit growth in revenues and also a double digit return on sales and H1 has absolutely shown the great potential for the Group. In light of the businesses' momentum and strong cash conversion, a resumption of Alumasc's previous dividend policy is being considered by the Board."

This announcement contains inside information.

Enquiries:

Paul Hooper, CEO

Helen Ashton, Group Company Secretary

+ 44 (0) 1536 383844

+ 44 (0) 1536 383812

 

Peel Hunt (Broker)

Mike Bell + 44 (0)207 418 8831

 

finnCap (NOMAD)

Julian Blunt + 44 (0)207 220 0561

Camarco:

Ginny Pulbrook + 44 (0)203 757 4992

Tom Huddart + 44 (0)203 757 4991

Email: alumasc@camarco.co.uk

 

 

Notes to Editors:

Alumasc is a UK-based supplier of premium building products, systems and solutions. Almost 80% of group sales are driven by building regulations and specifications (architects and structural engineers) because of the performance characteristics offered.

 

The Group has three business segments with strong positions and brands in their individual markets. The three segments are: Water Management; Building Envelope; and Housebuilding Products.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSRLFITLIL
Date   Source Headline
5th Feb 20137:00 amRNSHalf Yearly Report
21st Dec 20127:00 amRNSTrading Statement
3rd Dec 20127:00 amRNSAcquisition
14th Nov 201212:08 pmRNSSignificant Orders
2nd Nov 20123:44 pmRNSDirector/PDMR Shareholding
26th Oct 20121:58 pmRNSResult of AGM
25th Oct 20127:00 amRNSInterim Management Statement
4th Sep 20127:01 amRNSFinal Results
4th Sep 20127:00 amRNSAppointment of Non-Executive Director
17th Aug 20127:00 amRNSNotification of full year results
31st May 20127:00 amRNSSignificant Order
18th May 20123:22 pmRNSDirector/PDMR Shareholding
18th May 20127:00 amRNSInterim Management Statement
16th Apr 20129:08 amRNSSignificant order
26th Mar 20129:33 amRNSMajor Order
14th Mar 20124:30 pmRNSDirector/PDMR Shareholding - Correction
16th Feb 20122:59 pmRNSDirector/PDMR Shareholding
16th Feb 20127:00 amRNSInterim Results Announcement
27th Jan 20123:05 pmRNSDirector/PDMR Shareholding
20th Jan 20127:00 amRNSInterim results date
19th Jan 20127:00 amRNSSenior Management Change
12th Jan 20127:00 amRNSTrading Statement
14th Nov 20112:46 pmRNSDirector/PDMR Shareholding
28th Oct 20113:03 pmRNSResult of AGM
27th Oct 20117:00 amRNSInterim Management Statement
19th Oct 201111:18 amRNSHolding(s) in Company
21st Sep 20114:37 pmRNSAnnual Report and Notice of Annual General Meeting
6th Sep 20117:00 amRNSANNUAL RESULTS ANNOUNCEMENT
15th Jul 20117:00 amRNSTrading Statement
16th Jun 20117:00 amRNSRe Banking Facilities
23rd May 201110:55 amRNSBad Debt
20th May 20114:32 pmRNSHolding(s) in Company
19th May 20119:12 amRNSInterim Management Statement
9th May 20113:56 pmRNSHolding(s) in Company
9th May 20113:50 pmRNSHolding(s) in Company
12th Apr 20117:00 amRNSDisposal
28th Mar 20117:00 amRNSDisposal
3rd Feb 20117:00 amRNSHalf Yearly Report
7th Jan 20117:00 amRNSInterim results date
5th Nov 20102:41 pmRNSAnnual Information Update
29th Oct 20103:52 pmRNSResult of AGM
28th Oct 20107:00 amRNSInterim Management Statement
24th Sep 20103:59 pmRNSAnnual Report and Notice of Annual General Meeting
17th Sep 20103:49 pmRNSDirector/PDMR Shareholding
9th Sep 20104:24 pmRNSDirector/PDMR Shareholding
9th Sep 20107:00 amRNSAnnual Results Announcement
3rd Sep 20102:51 pmRNSAwards under The Alumasc Long Term Incentive Plan
9th Aug 20107:00 amRNSNotice of Results
18th May 20102:24 pmRNSBlocklisting Interim Review
1st Apr 20102:28 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.